Literature DB >> 9931060

Arsenic speciation in human organs following fatal arsenic trioxide poisoning--a case report.

L Benramdane1, M Accominotti, L Fanton, D Malicier, J J Vallon.   

Abstract

The aim of this investigation was to study the distribution of arsenic species in human organs following fatal acute intoxication by arsenic trioxide. The collected autopsy samples of most organs were ground and dried, and the total arsenic was measured by electrothermal atomic absorption spectrometry (ETAAS). The arsenic species--inorganic arsenic, in the form of arsenite [As(III)] and arsenate [As(V)], and its metabolites [monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA)]--were quantified by ETAAS after extraction with methanol/water (1:1, by volume) and separation by HPLC. The results indicate that after acute intoxication, the liver and kidneys show the highest concentrations of total arsenic and that the total concentration in blood is 7- to 350-fold less concentrated than in organs. In all organs, As(III) is the predominant species, and MMA is more concentrated than DMA. MMA and DMA are more prevalent in lipidic organs (49% of total arsenic) compared with other organs (25% of total arsenic). As(V) was found in small quantities in the liver, kidneys, and blood.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9931060

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  18 in total

1.  Precancerous and non-cancer disease endpoints of chronic arsenic exposure: the level of chromosomal damage and XRCC3 T241M polymorphism.

Authors:  Manjari Kundu; Pritha Ghosh; Sanhita Mitra; J K Das; T J Sau; Saptarshi Banerjee; J Christopher States; Ashok K Giri
Journal:  Mutat Res       Date:  2010-10-28       Impact factor: 2.433

Review 2.  Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals.

Authors:  David J Thomas; Jiaxin Li; Stephen B Waters; Weibing Xing; Blakely M Adair; Zuzana Drobna; Vicenta Devesa; Miroslav Styblo
Journal:  Exp Biol Med (Maywood)       Date:  2007-01

3.  Arsenic inhibits mast cell degranulation via suppression of early tyrosine phosphorylation events.

Authors:  Juyoung Shim; Rachel H Kennedy; Lisa M Weatherly; Lee M Hutchinson; Jonathan H Pelletier; Hina N Hashmi; Kayla Blais; Alejandro Velez; Julie A Gosse
Journal:  J Appl Toxicol       Date:  2016-03-28       Impact factor: 3.446

4.  Arsenic, cadmium, lead and mercury levels in blood of Finnish adults and their relation to diet, lifestyle habits and sociodemographic variables.

Authors:  Khaled Abass; Markku Koiranen; Darja Mazej; Janja Snoj Tratnik; Milena Horvat; Jukka Hakkola; Marjo-Riitta Järvelin; Arja Rautio
Journal:  Environ Sci Pollut Res Int       Date:  2016-10-24       Impact factor: 4.223

5.  Arsenic and manganese alter lead deposition in the rat.

Authors:  V Andrade; M L Mateus; D Santos; M Aschner; M C Batoreu; A P Marreilha dos Santos
Journal:  Biol Trace Elem Res       Date:  2014-04-09       Impact factor: 3.738

6.  Elevated Arsenic Exposure Is Associated with an Increased Risk of Chronic Hepatitis B Virus Infection: NHANES (2003-2014) in U.S. Adults.

Authors:  Wei-Hua Zhang; Jiao Huang; Mei Feng; Ye-Qing Tong; Xu-Hua Guan; Hong-Wei Jiang; Sheng Wei
Journal:  Curr Med Sci       Date:  2018-08-20

Review 7.  The case for visual analytics of arsenic concentrations in foods.

Authors:  Matilda O Johnson; Hari H P Cohly; Raphael D Isokpehi; Omotayo R Awofolu
Journal:  Int J Environ Res Public Health       Date:  2010-04-28       Impact factor: 3.390

Review 8.  Acute and chronic arsenic toxicity.

Authors:  R N Ratnaike
Journal:  Postgrad Med J       Date:  2003-07       Impact factor: 2.401

9.  Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic arsenic and its mono- and di-methylated metabolites.

Authors:  Hisham A El-Masri; Elaina M Kenyon
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-10-18       Impact factor: 2.745

10.  Arsenic exposure through drinking water increases the risk of liver and cardiovascular diseases in the population of West Bengal, India.

Authors:  Nandana Das; Somnath Paul; Debmita Chatterjee; Nilanjana Banerjee; Niladri S Majumder; Nilendu Sarma; Tanmoy J Sau; Santanu Basu; Saptarshi Banerjee; Papiya Majumder; Apurba K Bandyopadhyay; J Christopher States; Ashok K Giri
Journal:  BMC Public Health       Date:  2012-08-10       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.